5-HT1A receptors, gene repression, and depression: Guilt by association

Neuroscientist

Volumn 10, Issue 6, 2004, Pages 575-593

  Albert, Paul R ^a   Lemonde, Sylvie ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Anxiety; Hippocampus; Mood disorders; Raphe; SSRI; Stress

Indexed keywords

ANTIDEPRESSANT AGENT; APREPITANT; AUTORECEPTOR; FLUOXETINE; PINDOLOL; PROTEIN DEAF1; PROTEIN FREUD1; PROTEIN HES5; PROTEIN NRSF; PROTEIN NUDR; PROTEIN REST; REPRESSOR PROTEIN; SEROTONIN 1A RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; BRAIN CORTEX; CONTROLLED STUDY; DEPRESSION; DISEASE PREDISPOSITION; DRUG RECEPTOR BINDING; GENE EXPRESSION REGULATION; GENE REPRESSION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HUMAN; HUMAN CELL; HUMAN TISSUE; KNOCKOUT GENE; LATENT PERIOD; LIMBIC CORTEX; MAJOR DEPRESSION; MENTAL DISEASE; MOUSE; NONHUMAN; PANIC; PHENOTYPE; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; RECEPTOR GENE; REGULATORY MECHANISM; REVIEW; SEROTONIN RELEASE; SUICIDE; TRANSCRIPTION REGULATION;

ANIMALS; BRAIN; DEPRESSIVE DISORDER, MAJOR; DISEASE MODELS, ANIMAL; GENES, REGULATOR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; RECEPTOR, SEROTONIN, 5-HT1A; REPRESSOR PROTEINS; SEROTONIN;

EID: 9144264524     PISSN: 10738584     EISSN: None     Source Type: Journal    
DOI: 10.1177/1073858404267382     Document Type: Review

References (165)

1. Abdouh M, Storring JM, Riad M, Raquette Y, Albert PR, Drobetsky E, and others. 2001. Transcriptional mechanisms for induction of 5-HT1A receptor mRNA and protein in activated B and T lymphocytes. J Biol Chem 276:4382-8.
2. Albert PR, Lembo P, Starring JM, Charest A, Saucier C. 1996. The 5-HT1A receptor: signaling, desensitization, and gene transcription. Neuropsychopharmacology 14:19-25.
3. Albert PR, Sajedi N, Lemonde S, Ghahremani MH. 1999. Constitutive G(i2)-dependent activation of adenylyl cyclase type II by the 5-HT1A receptor. Inhibition by anxiolytic partial agonists. J Biol Chem 274:35469-74.
4. Albert PR, Zhou QY, Van Tol HH, Bunzow JR, Civelli O. 1990. Cloning, functional expression, and mRNA tissue distribution of the rat 5-hydroxytryptamine 1A receptor gene. J Biol Chem 265:5825-32.
5. Altar CA, Laeng P, Jurata LW, Brockman JA, Lemire A, Bullard J, and others. 2004. Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways. J Neurosci 24:2667-77.
6. Arango V, Huang Y, Underwood MD, Mann JJ. 2003. Genetics of the serotonergic system in suicidal behavior. J Psychiatr Res 37:375-86.
7. Arango V, Underwood MD, Boldrini M, Tamir H, Kassir SA, Hsiung S, and others. 2001. Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology 25:892-903.
8. Arborelius L, Linner L, Wallsten C, Ahlenius S, Svensson TH. 2000. Partial 5-HT1A receptor agonist properties of (-)pindolol in combination with citalopram on serotonergic dorsal raphe cell firing in vivo. Psychopharmacology (Berl) 151:77-84.
9. Arias B, Arranz MJ, Gasto C, Catalan R, Pintor L, Gutierrez B, and others. 2002. Analysis of structural polymorphisms and C-1018G promoter variant of the 5-HT(1A) receptor gene as putative risk factors in major depression. Mol Psychiatry 7:930-2.
10. Arias B, Arranz MJ, Gasto C, Catalan R, Pintor L, Gutierrez B, and others. 2003. Analysis of structural polymorphisms and C-1018G promoter variant of the 5-HT(1A) receptor gene as putative risk factors in major depression. Mol Psychiatry 8:246.
11. Artigas F, Celada P, Laruelle M, Adell A. 2001. How does pindolol improve antidepressant action? Trends Pharmacol Sci 22:224-8.
12. Artigas F, Romero L, de Montigny C, Blier P 1996. Acceleration of the effect of selected antidepressant drugs in major depression by 5-ht1a antagonists. Trends Neurosci 19:378-83.
13. Austin MC, Whitehead RE, Edgar CL, Janosky JE, Lewis DA. 2002. Localized decrease in serotonin transporter-immunoreactive axons in the prefrontal cortex of depressed subjects committing suicide. Neuroscience 114:807-15.
14. Azmitia EC. 2001. Modern views on an ancient chemical: serotonin effects on cell proliferation, maturation, and apoptosis. Brain Res Bull 56:413-24.
15. Aznar S, Qian Z, Shah R, Rahbek B, Knudsen GM. 2003. The 5-HT1A serotonin receptor is located on calbindin- and parvalbumin-containing neurons in the rat brain. Brain Res 959:58-67.
16. Barnes NM, Sharp T. 1999. A review of central 5-HT receptors and their function. Neuropharmacology 38:1083-152.
17. Benninghoff J, Schmitt A, Mossner R, Lesch KP. 2002. When cells become depressed: focus on neural stem cells in novel treatment strategies against depression. J Neural Transm 109:947-62.
18. Berrettini WH. 2000. Genetics of psychiatric disease. Annu Rev Med 51:465-79.
19. Blier P, de Montigny C. 1999. Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders. Neuropsychopharmacology 21:91S-8S.
20. Blier P, Ward NM. 2003. Is there a role for 5-HT(1A) agonists in the treatment of depression? Biol Psychiatry 53:193-203.
21. Bottomley MJ, Collard MW, Huggenvik JI, Liu Z, Gibson TJ, Sattler M. 2001. The SAND domain structure defines a novel DNA-binding fold in transcriptional regulation. Nat Struct Biol 8: 626-33.
22. Bremner JD, Vythilingam M, Vermetten E, Vaccarino V, Charney DS. 2004. Deficits in hippocampal and anterior cingulate functioning during verbal declarative memory encoding in midlife major depression. Am J Psychiatry 161:637-45.
23. Burnet PW, Eastwood SL, Harrison PJ. 1997. [3H]WAY-100635 for 5-HT1A receptor autoradiography in human brain: a comparison with [3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia. Neurochem Int 30:565-74.
24. Campbell S, Marriott M, Nahmias C, MacQueen GM. 2004. Lower hippocampal volume in patients suffering from depression: a metaanalysis. Am J Psychiatry 161:598-607.
25. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, and others. 2003. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301:386-9.
26. Celada P, Puig MV, Casanovas JM, Guillazo G, Artigas F. 2001. Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: Involvement of serotonin-1A, GABA(A), and glutamate receptors. J Neurosci 21:9917-29.
27. Champoux M, Bennett A, Shannon C, Higley JD, Lesch KP, Suomi SJ. 2002. Serotonin transporter gene polymorphism, differential early rearing, and behavior in rhesus monkey neonates. Mol Psychiatry 7:1058-63.
28. Charest A, Wainer BH, Albert PR. 1993. Cloning and differentiation- induced expression of a murine serotonin1A receptor in a septal cell line. J Neurosci 13:5164-71.
29. Charney DS, Krystal JH, Delgado PL, Heninger GR. 1990. Serotonin-specific drugs for anxiety and depressive disorders. Annu Rev Med 41:437-46.
30. Chinnadurai G. 2002. CtBP, an unconventional transcriptional corepressor in development and oncogenesis. Mol Cell 9:213-24.
31. Clarke WP, Yocca FD, Maayani S. 1996. Lack of 5-hydroxytryptamine1A- mediated inhibition of adenylyl cyclase in dorsal raphe of male and female rats. J Pharmacol Exp Ther 277:1259-66.
32. Conti AC, Cryan JF, Dalvi A, Lucki I, Blendy JA. 2002. cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs. J Neurosci 22:3262-8.
33. Coyle JT, Duman RS. 2003. Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron 38:157-60.
34. Del Tredici AL, Schiffer HH, Burstein ES, Lameh J, Mohell N, Hacksell U, and others. 2004. Pharmacology of polymorphic variants of the human 5-HT1A receptor. Biochem Pharmacol 67:479-90.
35. Doris A, Ebmeier K, Shajahan P. 1999. Depressive illness. Lancet 354:1369-75.
36. Drevets WC, Frank E, Price JC, Kupfer DJ, Greer PJ, Mathis C. 2000. Serotonin type-1A receptor imaging in depression. Nucl Med Biol 27:499-507.
37. Drevets WC, Frank E, Price JC, Kupfer DJ, Holt D, Greer PJ, and others. 1999. PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry 46:1375-87.
38. Duman RS. 2004. Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromol Med 5:11-26.
39. Erdmann J, Shimron-Abarbanell D, Cichon S, Albus M, Maier W, Lichtermann D, and others. 1995. Systematic screening for mutations in the promoter and the coding region of the 5-HT1A gene. Am J Med Genet 60:393-9.
40. Fabel K, Tam B, Kaufer D, Baiker A, Simmons N, Kuo CJ, and others. 2003. VEGF is necessary for exercise-induced adult hippocampal neurogenesis. Eur J Neurosci 18:2803-12.
41. Faber KM, Haring JH. 1999. Synaptogenesis in the postnatal rat fascia dentata is influenced by 5-HT1a receptor activation. Brain Res Dev Brain Res 114:245-52.
42. Fabre V, Beaufour C, Evrard A, Rioux A, Hanoun N, Lesch KP, and others. 2000. Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter. Eur J Neurosci 12:2299-310.
43. Fava M, Kendler KS. 2000. Major depressive disorder. Neuron 28:335-41.
44. Ferguson SS. 2001. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev 53:1-24.
45. Frodl T, Meisenzahl EM, Zill P, Baghai T, Rujescu D, Leinsinger G, and others. 2004. Reduced hippocampal volumes associated with the long variant of the serotonin transporter polymorphism in major depression. Arch Gen Psychiatry 61:177-83.
46. Fuks F, Hurd PJ, Wolf D, Nan X, Bird AP, Kouzarides T. 2003. The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J Biol Chem 278:4035-40.
47. Galter D, Unsicker K. 2000. Sequential activation of the 5-HT1(A) serotonin receptor and TrkB induces the serotonergic neuronal phenotype. Mol Cell Neurosci 15:446-55.
48. Gobbi G, Murphy DL, Lesch K, Blier P. 2001. Modifications of the serotonergic system in mice lacking serotonin transporters: an in vivo electrophysiological study. J Pharmacol Exp Ther 296:987-95.
49. Greden JF. 2001. The burden of recurrent depression: causes, consequences, and future prospects. J Clin Psychiatry 62:5-9.
50. Gross C, Zhuang X, Stark K, Ramboz S, Oosting R, Kirby L, and others. 2002. Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 416:396-400.
51. Gur E, Dremencov E, Garcia F, Van de Kar LD, Lerer B, Newman ME. 2002. Functional effects of chronic electroconvulsive shock on serotonergic 5-HT(1A) and 5-HT(1B) receptor activity in rat hippocampus and hypothalamus. Brain Res 952:52-60.
52. Gur E, Lerer B, Dremencov E, Newman ME. 2000. Chronic repetitive transcranial magnetic stimulation induces subsensitivity of presynaptic serotonergic autoreceptor activity in rat brain. Neuroreport 11:2925-9.
53. Gur E, Lifschytz T, Lerer B, Newman ME. 2002. Effects of triiodothyronine and imipramine on basal 5-HT levels and 5-HT(1) autoreceptor activity in rat cortex. Eur J Pharmacol 457:37-43.
54. Haddjeri N, de Montigny C, Blier P. 1999. Modulation of the firing activity of rat serotonin and noradrenaline neurons by (+/-)pindolol. Biol Psychiatry 45:1163-9.
55. Hahm K, Sum EY, Fujiwara Y, Lindeman GJ, Visvader JE, Orkin SH. 2004. Defective neural tube closure and anteroposterior patterning in mice lacking the LIM protein LMO4 or its interacting partner Deaf-1. Mol Cell Biol 24:2074-82.
56. Hajos M, Hajos-Korcsok E, Sharp T. 1999. Role of the medial prefrontal cortex in 5-HT1A receptor-induced inhibition of 5-HT neuronal activity in the rat. Br J Pharmacol 126:1741-50.
57. Hamer D. 2002. Genetics. Rethinking behavior genetics. Science 298:71-2.
58. Hanley NR, Van de Kar LD. 2003. Serotonin and the neuroendocrine regulation of the hypothalamic-pituitary-adrenal axis in health and disease. Vitam Horm 66:189-255.
59. Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D, and others. 2002. Serotonin transporter genetic variation and the response of the human amygdala. Science 297:400-3.
60. He M, Sibille E, Benjamin D, Toth M, Shippenberg T. 2001. Differential effects of 5-HT1A receptor deletion upon basal and fluoxetine-evoked 5-HT concentrations as revealed by in vivo microdialysis. Brain Res 902:11-17.
61. Heisler LK, Chu HM, Brennan TJ, Danao JA, Bajwa P, Parsons LH, and others. 1998. Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proc Natl Acad Sci U S A 95:15049-54.
62. Hendricks T, Francis N, Fyodorov D, Deneris ES. 1999. The ETS domain factor Pet-1 is an early and precise marker of central serotonin neurons and interacts with a conserved element in serotonergic genes. J Neurosci 19:10348-56.
63. Hendricks TJ, Fyodorov DV, Wegman LJ, Lelutiu NB, Pehek EA, Yamamoto B, and others. 2003. Pet-1 ETS gene plays a critical role in 5-HT neuron development and is required for normal anxiety-like and aggressive behavior. Neuron 37:233-47.
64. Hensler JG, Ladenheim EE, Lyons WE. 2003. Ethanol consumption and serotonin-1A (5-HT1A) receptor function in heterozygous BDNF (+/-) mice. J Neurochem 85:1139-47.
65. Hervas I, Vilaro MT, Romero L, Scorza MC, Mengod G, Artigas F. 2001. Desensitization of 5-HT(1A) autoreceptors by a low chronic fluoxetine dose effect of the concurrent administration of WAY-100635. Neuropsychopharmacology 24:11-20.
66. Hjorth S, Bengtsson HJ, Kullberg A, Carlzon D, Peilot H, Auerbach SB. 2000. Serotonin autoreceptor function and antidepressant drug action. J Psychopharmacol 14:177-85.
67. Holmes A, Murphy DL, Crawley JN. 2003. Abnormal behavioral phenotypes of serotonin transporter knockout mice: parallels with human anxiety and depression. Biol Psychiatry 54:953-9.
68. Hoyer D, Martin G. 1997. 5-HT receptor classification and nomenclature: towards a harmonization with the human genome. Neuropharmacology 36:419-28.
69. Hsiung SC, Adlersberg M, Arango V, Mann JJ, Tamir H, Liu KP. 2003. Attenuated 5-HT1A receptor signaling in brains of suicide victims: involvement of adenylyl cyclase, phosphatidylinositol 3-kinase, Akt and mitogen-activated protein kinase. J Neurochem 87:182-94.
70. Hyman S. 2000. Mental illness: genetically complex disorders of neural circuitry and neural communication. Neuron 28:321-3.
71. Jacobs BL, Azmitia EC. 1992. Structure and function of the brain serotonin system. Physiol Rev 72:165-229.
72. Johansson C, Jansson M, Linner L, Yuan QP, Pedersen NL, Blackwood D, and others. 2001. Genetics of affective disorders. Eur Neuropsychopharmacol 11:385-94.
73. Kageyama R, Ohtsuka T. 1999. The Notch-Hes pathway in mammalian neural development. Cell Res 9:179-88.
74. Kawanishi Y, Harada S, Tachikawa H, Okubo T, Shiraishi H. 1998. Novel mutations in the promoter and coding region of the human 5-HT1A receptor gene and association analysis in schizophrenia. Am J Med Genet 81:434-9.
75. Lee HJ, Elliot GJ, Hammond DN, Lee VM, Wainer BH. 1991. Constitutive expression of the mature array of neurofilament proteins by a CNS neuronal cell line. Brain Res 558:197-208.
76. Lee SJ, McEwen BS. 2001. Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications. Annu Rev Pharmacol Toxicol 41:569-91.
77. Lemonde S, Rogaeva A, Albert PR. 2004. Cell type-dependent recruitment of trichostatin A-sensitive repression of the human 5-HT1A receptor gene. J Neurochem 88:857-68.
78. Lemonde S, Turecki G, Bakish D, Du L, Hrdina PD, Bown CD, and others. 2003. Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neuroscience 23:8788-99.
79. Lesen KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, and others. 1996. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region [see comments]. Science 274:1527-31.
80. Lesch KP, Heils A. 2000. Serotonergic gene transcriptional control regions: targets for antidepressant drug development? Int J Neuropsychopharmacol 3:67-79.
81. Lesch KP, Zeng Y, Reif A, Gutknecht L. 2003. Anxiety-related traits in mice with modified genes of the serotonergic pathway. Eur J Pharmacol 480:185-204.
82. Liu D, Diorio J, Day JC, Francis DD, Meaney MJ. 2000. Maternal care, hippocampal synaptogenesis and cognitive development in rats. Nat Neurosci 3:799-806.
83. Lopez JF, Chalmers DT, Little KY, Watson SJ. 1998. A.E. Bennett Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biol Psychiatry 43:547-73.
84. Lopez JF, Liberzon I, Vazquez DM, Young EA, Watson SJ. 1999. Serotonin 1A receptor messenger RNA regulation in the hippocampus after acute stress. Biol Psychiatry 45:934-7.
85. Lopez-Figueroa AL, Norton CS, Lopez-Figueroa MO, Armellini-Dodel D, Burke S, Akil H, and others. 2004. Serotonin 5-HT1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia. Biol Psychiatry 55:225-33.
86. MacQueen GM, Campbell S, McEwen BS, Macdonald K, Amano S, Joffe RT, and others. 2003. Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci U S A 100:1387-92.
87. Malberg JE, Duman RS. 2003. Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment. Neuropsychopharmacology 28:1562-71.
88. Malberg JE, Eisch AJ, Nestler EJ, Duman RS. 2000. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20:9104-10.
89. Mann JJ, Huang YY, Underwood MD, Kassir SA, Oppenheim S, Kelly TM, and others. 2000. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatry 57:729-38.
90. Mannoury la Cour C, Boni C, Hanoun N, Lesch KP, Hamon M, Lanfumey L. 2001. Functional consequences of 5-HT transporter gene disruption on 5-HT(1a) receptor-mediated regulation of dorsal raphe and hippocampal cell activity. J Neurosci 21:2178-85.
91. Martin-Ruiz R, Puig MV, Celada P, Shapiro DA, Roth BL, Mengod G, and others. 2001. Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism. J Neurosci 21:9856-66.
92. Martinez D, Hwang D, Mawlawi O, Slifstein M, Kent J, Simpson N, and others. 2001. Differential occupancy of somatodendritic and postsynaptic 5HT(1A) receptors by pindolol: a dose-occupancy study with [11C]WAY 100635 and positron emission tomography in humans. Neuropsychopharmacology 24:209-29.
93. Matsuda A, Suzuki Y, Honda G, Muramatsu S, Matsuzaki O, Nagano Y, and others. 2003. Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways. Oncogene 22:3307-18.
94. Mayberg HS. 2003. Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. Br Med Bull 65:193-207.
95. McEwen BS. 1999. Stress and hippocampal plasticity. Annu Rev Neurosci 22:105-22.
96. McEwen BS. 2001. Plasticity of the hippocampus: adaptation to chronic stress and allostatic load. Ann N Y Acad Sci 933:265-77.
97. Meaney MJ. 2001. Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. Annu Rev Neurosci 24:1161-92.
98. Meijer OC, de Kloet ER. 1998. Corticosterone and serotonergic neurotransmission in the hippocampus: functional implications of central corticosteroid receptor diversity. Crit Rev Neurobiol 12:1-20.
99. Mendelson SD, McEwen BS. 1992. Quantitative autoradiographic analyses of the time course and reversibility of corticosterone-induced decreases in binding at 5-HT1A receptors in rat forebrain. Neuroendocrinology 56:881-8.
100. Michelson RJ, Collard MW, Ziemba AJ, Persinger J, Bartholomew B, Huggenvik JI. 1999. Nuclear DEAF-1-related (NUDR) protein contains a novel DNA binding domain and represses transcription of the heterogeneous nuclear ribonucleoprotein A2/B1 promoter. J Biol Chem 274:30510-19.
101. Miller HL, Delgado PL, Salomon RM, Licinio J, Barr LC, Charney DS. 1992. Acute tryptophan depletion: a method of studying antidepressant action. J Clin Psychiatry 53(Suppl):28-35.
102. Moore P, Landolt HP, Seifritz E, Clark C, Bhatti T, Kelsoe J, and others. 2000. Clinical and physiological consequences of rapid tryptophan depletion. Neuropsychopharmacology 23:601-22.
103. Moreno FA, Rowe DC, Kaiser B, Chase D, Michaels T, Gelernter J, and others. 2002. Association between a serotonin transporter promoter region polymorphism and mood response during tryptophan depletion. Mol Psychiatry 7:213-16.
104. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. 2002. Neurobiology of depression. Neuron 34:13-25.
105. Neumeister A, Bain E, Nugent AC, Carson RE, Bonne O, Luckenbaugh DA, and others. 2004. Reduced serotonin type 1A receptor binding in panic disorder. J Neurosci 24:589-91.
106. Neumeister A, Konstantinidis A, Stastny J, Schwarz MJ, Vitouch O, Willeit M, and others. 2002. Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression. Arch Gen Psychiatry 59:613-20.
107. Ou XM, Jafar-Nejad H, Storring JM, Meng JH, Lemonde S, Albert PR. 2000. Novel dual represser elements for neuronal cell-specific transcription of the rat 5-HT1A receptor gene. J Biol Chem 275:8161-8.
108. Ou XM, Lemonde S, Jafar-Nejad H, Bown CD, Goto A, Rogaeva A, and others. 2003. Freud-1: a novel calcium-regulated repressor of the 5-HT1A receptor gene. J Neurosci 23:7415-25.
109. Ou XM, Storring JM, Kushwaha N, Albert PR. 2001. A novel negative response element for transrepression of the 5-HT1A receptor gene by mineralocorticoid/glucocorticoid receptor heterodimerization. J Biol Chem 276:14299-307.
110. Parks CL, Robinson PS, Sibille E, Shenk T, Toth M. 1998. Increased anxiety of mice lacking the serotonin1A receptor. Proc Natl Acad Sci U S A 95:10734-9.
111. Parks CL, Shenk T. 1996. The serotonin 1a receptor gene contains a TATA-less promoter that responds to MAZ and Sp1. J Biol Chem 271:4417-30.
112. Parsons LH, Kerr TM, Tecott LH. 2001. 5-HT(1A) receptor mutant mice exhibit enhanced tonic, stress-induced and fluoxetine-induced serotonergic neurotransmission. J Neurochem 77:607-17.
113. Pineyro G, Blier P. 1999. Autoregulation of serotonin neurons: role in antidepressant drug action. Pharmacol Rev 51:533-91.
114. Rabiner EA, Gunn RN, Castro ME, Sargent PA, Cowen PJ, Koepp MJ, and others. 2000. Beta-blocker binding to human 5-HT(1A) receptors in vivo and in vitro: implications for antidepressant therapy. Neuropsychopharmacology 23:285-93.
115. Rajkowska G. 2000. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol Psychiatry 48:766-77.
116. Rajkowska G. 2003. Depression: what we can learn from postmortem studies. Neuroscientist 9:273-84.
117. Ramboz S, Oosting R, Amara DA, Kung HF, Blier P, Mendelsohn M, and others. 1998. Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proc Natl Acad Sci USA 95:14476-81.
118. Raymond JR, Mukhin YV, Gettys TW, Garnovskaya MN. 1999. The recombinant 5-HT1A receptor: G protein coupling and signalling pathways. Br J Pharmacol 127:1751-64.
119. Reif A, Lesch KP. 2003. Toward a molecular architecture of personality. Behav Brain Res 139:1-20.
120. Riad M, Garcia S, Watkins KC, Jodoin N, Doucet E, Langlois X, and others. 2000. Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain. J Comp Neurol 417:181-94.
121. Riad M, Watkins KC, Doucet E, Hamon M, Descarries L. 2001. Agonist-induced internalization of serotonin-1a receptors in the dorsal raphe nucleus (autoreceptors) but not hippocampus (heteroreceptors). J Neurosci 21:8378-86.
122. Rothe C, Gutknecht L, Freitag C, Tauber R, Mossner R, Franke P, and others. 2004. Association of a functional-1019C>G 5-HT1A receptor gene polymorphism with panic disorder with agoraphobia, Int J Neuropsychopharmacol 7:1-4.
123. Rotondo A, Nielsen DA, Nakhai B, Hulihan-Giblin B, Bolos A, Goldman D. 1997. Agonist-promoted down-regulation and functional desensitization in two naturally occurring variants of the human serotonin1A receptor. Neuropsychopharmacology 17:18-26.
124. Rumajogee P, Madeira A, Verge D, Hamon M, Miquel M-C. 2002. Upregulation of the neuronal serotoninergic phenotype in vitro: BDNF and cAMP share Trk B-dependent mechanisms. J Neurochem 83:1525-8.
125. Rumajogee P, Verge D, Hanoun N, Brisorgueil MJ, Hen R, Lesch KP, and others. 2004. Adaption of the serotoninergic neuronal pheno-type in the absence of 5-HT autoreceptors or the 5-HT transporter: involvement of BDNF and cAMP Eur J Neurosci 19:937-44.
126. Rupniak NM, Kramer MS. 1999. Discovery of the antidepressant and anti-emetic efficacy of substance P receptor (NK1) antagonists. Trends Pharmacol Sci 20:485-90.
127. Saarelainen T, Hendolin P, Lucas G, Koponen E, Sairanen M, Mac Donald E, and others. 2003. Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J Neurosci 23:349-57.
128. Sakai K, Nakamura M, Ueno S, Sano A, Sakai N, Shirai Y, and others. 2002. The silencer activity of the novel human serotonin transporter linked polymorphic regions. Neurosci Lett 327:13-16.
129. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, and others. 2003. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301:805-9.
130. Santarelli N, Gross C, Monckton J, Dulawa S, Lee J, Saxe M, and others. 2001. The 5-HT1A receptor is required for the effect of chronic fluoxetine on behavior and neurogenesis. Proc Soc Neurosci 27:858-14.
131. Sargent PA, Kjaer KH, Bench CJ, Rabiner EA, Messa C, Meyer J, and others. 2000. Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Arch Gen Psychiatry 57:174-80.
132. Sarnyai Z, Sibille EL, Pavlides C, Fenster RJ, McEwen BS, Toth M. 2000. Impaired hippocampal-dependent learning and functional abnormalities in the hippocampus in mice lacking serotonin1A receptors. Proc Natl Acad Sci U S A 97:14731-6.
133. Schlechter MD, Chance WT. 1979. Non-specificity of "behavioral despair" as an animal model of depression. Eur J Pharmacol 60:139-42.
134. Schoenherr CJ, Anderson DJ. 1995. The neuron-restrictive silencer factor (NRSF): a coordinate repressor of multiple neuron-specific genes. Science 267:1360-3.
135. Schramm NL, McDonald MP, Limbird LE. 2001. The alpha(2a)-adrenergic receptor plays a protective role in mouse behavioral models of depression and anxiety. J Neurosci 21:4875-82.
136. Segurado R, Detera-Wadleigh SD, Levinson DF, Lewis CM, Gill M, Nurnberger JI Jr, and others. 2003. Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: bipolar disorder. Am J Hum Genet 73:49-62.
137. Shen C, Li H, Meller E. 2002. Repeated treatment with antidepressants differentially alters 5-HT1A agonist-stimulated [35S]GTP gamma S binding in rat brain regions. Neuropharmacology 42:1031-8.
138. Shenoy SK, Lefkowitz RJ. 2003. Multifaceted roles of beta-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling. Biochem J 375:503-15.
139. Shioe K, Ichimiya T, Suhara T. Takano A, Sudo Y, Yasuno F, and others. 2003. No association between genotype of the promoter region of serotonin transporter gene and serotonin transporter binding in human brain measured by PET. Synapse 48:184-8.
140. Sotelo C, Cholley B, El Mestikawy S. EM, Gozlan H, Hamon M. 1990. Direct immunohistochemical evidence of the existence of 5-HT1A autoreceptors on serotoninergic neurons in the midbrain raphe nuclei. Eur J Neurosci 2:1144-54.
141. Stahl SM. 1998. Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects. J Affect Disord 51:215-35.
142. Stephens JC. Schneider JA. Tanguay DA, Choi J, Acharya T, Stanley SE, and others. 2001. Haplotype variation and linkage disequilibrium in 313 human genes. Science 293:489-93.
143. Stockmeier CA, Shapiro LA, Dilley GE, Kolli TN, Friedman L, Rajkowska G. 1998. Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity. J Neurosci 18:7394-401.
144. Storring JM, Charest A, Cheng P, Albert PR. 1999. TATA-driven transcriptional initiation and regulation of the rat serotonin 5-HT1A receptor gene. J Neurochem 72:2238-47.
145. Strobel A, Gutknecht L, Rothe C, Reif A, Mossner R, Zeng Y, and others. 2003. Allelic variation in 5-HT(1A) receptor expression is associated with anxiety- and depression-related personality traits. J Neural Transm 110:1445-53.
146. Sumiyoshi T, Stockmeier CA, Overholser JC, Dilley GE, Meltzer HY. 1996. Serotonin1A receptors are increased in postmortem prefrontal cortex in schizophrenia. Brain Res 708:209-14.
147. Tauscher J, Kapur S, Verhoeff NP, Hussey DF, Daskalakis ZJ, Tauscher-Wisniewski S, and others. 2002. Brain serotonin 5-HT(1A) receptor binding in schizophrenia measured by positron emission tomography and [11C]WAY-100635. Arch Gen Psychiatry 59:514-20.
148. Törk I. 1990. Anatomy of the serotonergic system. Ann N Y Acad Sci 600:9-34; discussion 34-5.
149. Underwood MD, Khaibulina AA, Ellis SP, Moran A, Rice PM, Mann JJ, and others. 1999. Morphometry of the dorsal raphe nucleus serotonergic neurons in suicide victims. Biol Psychiatry 46:473-83.
150. Vazquez DM, Lopez JF, Van Hoers H, Watson SJ, Levine S. 2000. Maternal deprivation regulates serotonin 1A and 2A receptors in the infant rat. Brain Res 855:76-82.
151. Vazquez DM, Van Oers H, Levine S, Akil H. 1996. Regulation of glucocorticoid and mineralocorticoid receptor mRNAs in the hippocampus of the maternally deprived infant rat. Brain Res 731:79-90.
152. Veenstra-Vander Weele J, Anderson GM, Cook EH Jr. 2000. Pharmacogenetics and the serotonin system: initial studies and future directions. Eur J Pharmacol 410:165-81.
153. Vreugdenhil E, de Kloet ER, Schaaf M, Datson NA. 2001. Genetic dissection of corticosterone receptor function in the rat hippocampus. Eur Neuropsychopharmacol 11:423-30.
154. Walther DJ, Peter JU, Bashammakh S, Hortnagl H, Voits M, Fink H, and others. 2003. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 299:76.
155. Weaver IC, La Plante P, Weaver S, Parent A, Sharma S, Diorio J, and others. 2001. Early environmental regulation of hippocampal glucocorticoid receptor gene expression: characterization of intracellular mediators and potential genomic target sites. Mol Cell Endocrinol 185:205-18.
156. White LA, Eaton MJ, Castro MC, Klose KJ, Globus MY, Shaw G, and others. 1994. Distinct regulatory pathways control neurofilament expression and neurotransmitter synthesis in immortalized serotonergic neurons. J Neurosci 14:6744-53.
157. Wilson CC, Faber KM, Haring JH. 1998. Serotonin regulates synaptic connections in the dentate molecular layer of adult rats via 5-HT1a receptors: evidence for a glial mechanism. Brain Res 782:235-9.
158. Wissink S, Meijer O, Pearce D, van Der Burg B, van Der Saag PT. 2000. Regulation of the rat serotonin-1A receptor gene by corticosteroids. J Biol Chem 275:1321-6.
159. World Health Organization. 2001. The world health report 2001. Mental health, new understanding, new hope. Geneva, Switzerland: WHO Marketing and Dissemination.
160. Wu S, Comings DE. 1999. A common C-1018G polymorphism in the human 5-HT1A receptor gene. Psychiatr Genet 9:105-6.
161. Yan W, Wilson CC, Haring JH. 1997. Effects of neonatal serotonin depletion on the development of rat dentate granule cells. Brain Res Dev Brain Res 98:177-84.
162. Young SN. 1993. The use of diet and dietary components in the study of factors controlling affect in humans: a review. J Psychiatry Neurosci 18:235-44.
163. Yu F, Thiesen J, Stratling WH. 2000. Histone deacetylase-independent transcriptional repression by methyl- CpG-binding protein 2. Nucleic Acids Res 28:2201-6.
164. Zanardi R, Serretti A, Rossini D, Franchini L, Cusin C, Lattuada E, and others. 2001. Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression. Biol Psychiatry 50:323-30.
165. Zhong P, Ciaranello RD. 1995. Transcriptional regulation of hippocampal 5-HT1a receptors by corticosteroid hormones. Brain Res Mol Brain Res 29:23-34.